IP Library Assignment 037029/0657
Patent Assignment
Reel/Frame 037029/0657

Assignment of Assignor's Interest

Recorded: 2015-11-13 Pages: 3
Assignor
KHARBANDA, SURENDER
Executed: 2015-11-12
Assignee
GENUS ONCOLOGY, LLC
1550 N. CLEVELAND AVE., CHICAGO, ILLINOIS, 60610
Covered Property (1)
Combination Anti-Estrogen Receptor Cancer Therapy Using MUC1 Peptides and Chemotherapeutics
Patent: 9,572,855 →
Application: 14/774,163 →
Publication: US 2016/0058827
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 13, 2015
From: KUFE, DONALD W.
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 037029/0616 →
Confirmatory License Jul 25, 2016
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039452/0156 →